Phil Hykin

Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles

Jignesh Patel, Joyce Tombran‐Tink, Phil Hykin et al. · Experimental Eye Research · 2005 · 140 citations

Diabetic Retinopathy, Structural Differences, Ocular Disease +9

Caregiver Burden in Patients Receiving Ranibizumab Therapy for Neovascular Age Related Macular Degeneration

Rishma Gohil, Roxanne Crosby‐Nwaobi, Angus Forbes et al. · PLoS ONE · 2015 · 73 citations · Full text

MACULAR PERFUSION DETERMINED BY FUNDUS FLUORESCEIN ANGIOGRAPHY AT THE 4-MONTH TIME POINT IN A PROSPECTIVE RANDOMIZED TRIAL OF INTRAVITREAL BEVACIZUMAB OR LASER THERAPY IN THE MANAGEMENT OF DIABETIC MACULAR EDEMA (BOLT STUDY)

Michel Michaelides, Samantha Fraser‐Bell, Robin Hamilton et al. · Retina · 2010 · 68 citations

Injection frequency and response to bevacizumab monotherapy for diabetic macular oedema (BOLT Report 5)

Sobha Sivaprasad, Roxanne Crosby‐Nwaobi, Ling Zhi Heng et al. · British Journal of Ophthalmology · 2013 · 58 citations

Novel Mutations and Electrophysiologic Findings in RGS9- and R9AP-Associated Retinal Dysfunction (Bradyopsia)

Michel Michaelides, Zheng Li, Naheed A. Rana et al. · Ophthalmology · 2009 · 47 citations · Full text

R9ap-associated Retinal Dysfunction, Electrophysiologic Findings, Retina +9